Clik here to view.
Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019...
The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world’s first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related...
View ArticleClik here to view.
Penn’s Angela DeMichele, MD, MSCE Part of Team Awarded Stand Up 2 Cancer Grant
A new $3 million grant to support a clinical trial evaluating a combination therapy to prevent triple-negative breast cancer from recurring will be led in the clinic by Angela DeMichele, MD, MSCE, the...
View ArticleClik here to view.
Electric Pill Bottles and Text Messaging Not Enough to Affect Blood Pressure...
About one in three Americans have high blood pressure, called hypertension, but only about half of them have their condition under control.
View ArticleClik here to view.
Radiation May Lower Potential for Side Effects of CAR T Therapy in...
Treating non-Hodgkin’s lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side...
View ArticleClik here to view.
Opioid Prescriptions Filled After Eye Surgery Doubled from 2000 to 2014
From 2000 to 2014, rates of filled opioid prescriptions after eye surgery rose considerably, despite reduced invasiveness of these procedures, according to a new study by researchers in the Perelman...
View ArticleClik here to view.
A novel vaccine developed at Penn Medicine protected almost all animal...
Researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a vaccine to protect against genital herpes.
View ArticleClik here to view.
Oncologists Respond Swiftly to FDA Safety Alerts, Penn Study Finds
Within six months of the U.S. Food and Drug Administration’s (FDA) move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according...
View ArticleClik here to view.
Penn Team Creates First Bile Duct-On-A-Chip, Replicating the Structure and...
The small model — 4 millimeters long and 0.16 millimeters in diameter — now makes it possible for researchers to study the difficult-to-access tissue without the need for human participants or living...
View ArticleClik here to view.
Prediction System Significantly Increases Palliative Care Consults
Palliative Connect, a trigger system developed at Penn Medicine and powered by predictive analytics, was found to be effective at increasing palliative care consultations for seriously ill patients,...
View ArticleClik here to view.
Penn Researchers Receive $18 Million Grant to Study Connection Between...
The Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania has received a grant expected to total $18.1 million to study the underlying genetic mechanisms that cause...
View ArticleClik here to view.
The Missing Link: Can the Additive Tree Expand Machine Learning in Medicine?
As artificial intelligence’s footprint increases in medicine, that ability to check work and follow the path of a decision can become a bit muddied.
View ArticleClik here to view.
Mounting Brain Organoid Research Reignites Ethical Debate
Penn Neuroscientists Call for Ethical Framework Grounded in Scientific Principles for Transplanting Human “Mini-brains” into Animals as Field Evolves.
View ArticleClik here to view.
Penn Medicine Receives $22 Million from NIH HEAL Initiative to Address the...
Today, the National Institutes of Health (NIH) announced awards from the Helping to End Addiction Long-term Initiative (NIH HEAL Initiative), which was launched in April 2018 to improve prevention and...
View ArticleClik here to view.
Seven Penn Medicine Scientists Receive National Institutes of Health...
– For the second year in a row, the National Institutes of Health (NIH) has selected seven researchers from Penn to receive its prestigious Director’s Awards, part of the NIH’s High-Risk, High-Reward...
View ArticleClik here to view.
Treating Pulmonary Embolism: How Safe and Effective Are New Devices?
Pulmonary embolism (PE), a blood clot lodged in one of the pulmonary arteries in the lungs, is the third leading cause of cardiovascular-related death in the United States.
View ArticleClik here to view.
Penn developed Gene Therapy for Duchenne Muscular Dystrophy Safely Preserves...
A gene therapy being developed at Penn Medicine to treat Duchenne muscular dystrophy (DMD) successfully and safely stopped the severe muscle deterioration associated with the rare,
View ArticleClik here to view.
Online Patient Portal Usage Linked to Higher Rates of Flu Shots, Blood...
Penn Medicine study shows patients who use online platforms connected to their health records are more likely to take preventative health measures
View ArticleClik here to view.
Algorithm Personalizes Which Cancer Mutations Are Best Targets for Immunotherapy
As tumor cells multiply, they often spawn tens of thousands of genetic mutations. Figuring out which ones are the most promising to target with immunotherapy is like finding a few needles in a...
View ArticleClik here to view.
With $20 Million NIH Grant, Penn Researchers to Develop a Tool to Help...
Researchers in the Perelman School of Medicine at the University of Pennsylvania will lead a multi-institutional effort in pursuit of developing a critical tool for imaging the brains of patients with...
View ArticleClik here to view.
Awards & Accolades: September 2019
Learn how Penn clinicians and researchers are being honored by their peers.
View Article